{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:28:21Z","timestamp":1790094501940,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12098-017-2532-9","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T21:00:17Z","timestamp":1511384417000},"page":"139-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India"],"prefix":"10.1007","volume":"85","author":[{"given":"Jyoti","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoja Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Polpakara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satinder","family":"Aneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra Kumar","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"key":"2532_CR1","unstructured":"Centers for Disease Control and Prevention (CDC). Ten great public health achievements- United States, 1900\u20131999. MMWR Morb Mortal Wkly Rep. 1999;48:241\u20133. Available at : https:\/\/www.cdc.gov\/mmwr\/pdf\/wk\/mm6019.pdfDC MMWR. Accessed 2 Apr 2017."},{"key":"2532_CR2","unstructured":"WHO Immunization, Vaccines and Biologicals. World Immunization Week 2012. Available at : http:\/\/www.who.int\/immunization\/newsroom\/events\/immunization_week\/en\/. Accessed 2 Apr 2017."},{"key":"2532_CR3","unstructured":"CDC MMWR. Recommendations of the international task force for disease eradication. Centre for Disease Control and Prevention, Morbidity and Mortality Weekly Report; 1993;42:1\u201338. Available at : https:\/\/www.cdc.gov\/vaccines\/parents\/vaccine-decision\/index.html?s_cid=bb-vaccines-Child-HP03-NCIRD. Accessed 26 July 2017."},{"key":"2532_CR4","unstructured":"Miller ER, Haber P, Hibbs B, Broder K. Surveillance for adverse events following immunization using the vaccine adverse event reporting system (VAERS). In Roush SW, Baldy LM, editors. VPD surveillance manual, 5th ed. USA: Centre for Disease Control; 2011. p. 1\u201314. Available at : https:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt21-surv-adverse-events.pdf. Accessed 2 April 2017."},{"key":"2532_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/archpedi.158.6.569","volume":"158","author":"B Bardenheier","year":"2004","unstructured":"Bardenheier B, Yusuf H, Schwartz B, et al. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children? Arch Pediatr Adolesc Med. 2004;158:569\u201375.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2532_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1469-8749.2010.03781.x","volume":"52","author":"P Baxter","year":"2010","unstructured":"Baxter P. Pertussis vaccine encephalopathy: \u2018oh! Let us never, never doubt. Dev Med Child Neurol. 2010;52:883\u20134.","journal-title":"Dev Med Child Neurol"},{"key":"2532_CR7","doi-asserted-by":"publisher","first-page":"D46","DOI":"10.1016\/j.vaccine.2015.06.073","volume":"33","author":"RT Chen","year":"2015","unstructured":"Chen RT, Shimabukuro TT, Martin DB, Zuber PLF, Weibel DM, Sturkenboom M. Enhancing vaccine safety capacity globally: a lifecycle perspective. Vaccine. 2015;33:D46\u201354.","journal-title":"Vaccine"},{"key":"2532_CR8","doi-asserted-by":"publisher","unstructured":"Institute of Medicine. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. Available at: https:\/\/doi.org\/10.17226\/13164. Accessed 2 Apr 2017.","DOI":"10.17226\/13164"},{"key":"2532_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","volume":"351","author":"AJ Wakefield","year":"1998","unstructured":"Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637\u201341.","journal-title":"Lancet"},{"key":"2532_CR10","doi-asserted-by":"publisher","unstructured":"Anonymous. Retraction-Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet. 2010;375:445. https:\/\/doi.org\/10.1016\/S0140-6736(10)60175-4.","DOI":"10.1016\/S0140-6736(10)60175-4"},{"key":"2532_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/bmb\/ldh002","volume":"69","author":"MMMR Fitzpatrick","year":"2004","unstructured":"Fitzpatrick MMMR. Risk, choice, chance. Br Med Bull. 2004;69:143\u201353.","journal-title":"Br Med Bull"},{"key":"2532_CR12","doi-asserted-by":"crossref","unstructured":"Giannattasio A, Mariano M, Romano R, et al. Sustained low influenza vaccination in health care workers after H1N1 pandemic: a cross sectional study in an Italian health care setting for at-risk patients. BMC Infect Dis. 2015;15:329\u201336.","DOI":"10.1186\/s12879-015-1090-x"},{"key":"2532_CR13","doi-asserted-by":"publisher","unstructured":"Jegede AS. What led to the nigerian boycott of the polio vaccination campaign? PLoS Med. 2007;4:0417-22. https:\/\/doi.org\/10.1371\/journal.pmed.0040073","DOI":"10.1371\/journal.pmed.0040073"},{"key":"2532_CR14","first-page":"963","volume":"46","author":"S Chaturvedi","year":"2009","unstructured":"Chaturvedi S, Dasgupta R, Adhish V, et al. Deconstructing social resistance to pulse polio campaign in two north Indian districts. Indian Pediatr. 2009;46:963\u201374.","journal-title":"Indian Pediatr"},{"key":"2532_CR15","unstructured":"Media report. WhatsApp rumours about vaccinations hamper India's drive to halt measles and rubella, The government plans to extend the campaign by a week to achieve targets: February 24, 2017. Available at: https:\/\/scroll.in\/pulse\/830129\/rumours-about-measles-rubella-vaccine-hit-coverage. Accessed 2 Apr 2017."},{"key":"2532_CR16","unstructured":"States seek to allay fears over measles-rubella vaccine. January 29, 2017. Available at: http:\/\/www.thehindu.com\/news\/national\/States-seek-to-allay-fears-over-measles-rubella-vaccine\/article17110296.ece. Accessed 2 Apr 2017."},{"key":"2532_CR17","unstructured":"Integrated Child Health and Immunization Survey (INCHIS). Report- Rounds 1 & 2. 2016. Immunization technical support unit, Ministry of Health and Family Welfare, Government of India, New Delhi. Available at: http:\/\/www.itsu.org.in\/integrated-child-health-immunization-survey-inchis-report-rounds-1-2. Accessed 2 Apr 2017."},{"key":"2532_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/vaccines1030204","volume":"1","author":"K Hardt","year":"2013","unstructured":"Hardt K, Schmidt-Ott R, Glismann S, Adegbola RA, Meurice FP. Sustaining vaccine confidence in the 21st century. Vaccines (Basel). 2013;1:204\u201324.","journal-title":"Vaccines (Basel)"},{"key":"2532_CR19","unstructured":"WHO. Report Of the Sage working group on vaccine hesitancy. 2014. WHO, Geneva. Available at: http:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf. Accessed 2 Apr 2017."},{"key":"2532_CR20","unstructured":"National Regulatory Authority of India meets WHO International Standards for Vaccine Regulations, WHO India NRA Press Release. WHO country Office for India, February 21, 2017. Available at: http:\/\/www.searo.who.int\/india\/mediacentre\/events\/2017\/NRA2017\/en\/. Accessed 2 Apr 2017."},{"key":"2532_CR21","unstructured":"WHO. Vaccine safety basics: learning manual. 2013, WHO Press, Geneva. Available at: http:\/\/www.who.int\/vaccine_safety\/initiative\/tech_support\/Vaccine-safety-E-course-manual.pdf?ua=1. Accessed 2 Apr 2017."},{"key":"2532_CR22","unstructured":"WHO. Global manual on surveillance of adverse events following immunization, 2014. WHO Press, Geneva. Available at: http:\/\/www.who.int\/vaccine_safety\/publications\/Global_Manual_on_Surveillance_of_AEFI.pdf. Accessed 2 Apr 2017."},{"key":"2532_CR23","unstructured":"Operational Guidelines for AEFI Surveillance in India. Revised edition 2011. New Delhi: Ministry of Health and Family Welfare; 2011."},{"key":"2532_CR24","unstructured":"Operational Guidelines for AEFI Surveillance in India. Revised 2015. New Delhi: Ministry of Health and Family Welfare; 2015."},{"key":"2532_CR25","unstructured":"WHO. Immunization, vaccines and biologicals. Fact sheets. Available at: http:\/\/www.who.int\/immunization\/newsroom\/factsheets\/en\/. Accessed on July 25th 2017."},{"key":"2532_CR26","unstructured":"WHO. Causality Assessment of an Adverse Event Following Immunization (AEFI). user manual for the revised WHO classification, 2013. WHO Press. Available at: http:\/\/www.who.int\/vaccine_safety\/publications\/aevi_manual.pdf. Accessed 25 July 2017"},{"key":"2532_CR27","unstructured":"Results of causality assessment for reported AEFIs. Ministry of Health and Family Welfare, Government of India. Available at: http:\/\/mohfw.nic.in\/right-information-rti\/rti-act-for-ministry\/departments-health-and-family-welfare\/immunization. Accessed 25 July 2017."},{"key":"2532_CR28","unstructured":"Central AEFI Team Investigation Reports. Available at: http:\/\/mohfw.nic.in\/right-information-rti\/rti-act-for-ministry\/departments-health-and-family-welfare\/immunization\/aefi-reports. Accessed 25 July 2017."},{"key":"2532_CR29","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1016\/j.vaccine.2017.06.027","volume":"35","author":"AK Singh","year":"2017","unstructured":"Singh AK, Wagner AL, Joshi J, et al. Application of the revised WHO causality assessment protocol for adverse events following immunization in India. Vaccine. 2017;35:4197\u2013202.","journal-title":"Vaccine"},{"key":"2532_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12098-015-1844-x","volume":"83","author":"C Lahariya","year":"2015","unstructured":"Lahariya C, Paruthi R, Bhatacharya M. How a new health intervention affects the health systems? Learnings from pentavalent vaccine introduction in India. Indian J Pediatr. 2015;83:294\u20139.","journal-title":"Indian J Pediatr"},{"key":"2532_CR31","unstructured":"Communication Guidelines for HW for handling AEFIs. Available at: http:\/\/mohfw.nic.in\/sites\/default\/files\/2013%20Communication%20Guidelines%20for%20Building%20Vaccine%20Confidence%20around%20AEFI.pdf. Accessed 25 July 2017."},{"key":"2532_CR32","unstructured":"AEFI Media Communication Protocol. Available at: http:\/\/www.itsu.org.in\/repository-resources\/Aefi_media_communication_protocol.pdf. Accessed 25 July 2017."},{"key":"2532_CR33","unstructured":"Quality Policy for AEFI Surveillance Program. Available at: http:\/\/mohfw.nic.in\/sites\/default\/files\/AEFI%20Survellance%20Programme-Quality%20Policy%20and%20Objectives.pdf. Accessed 25 July 2017."},{"key":"2532_CR34","unstructured":"Press Information Bureau. Maximum Possible Marks to India in NRA Assessment. Ministry of Health and Family Welfare, Government of India. February 21, 2017. Available at: http:\/\/pib.nic.in\/newsite\/PrintRelease.aspx?relid=158598. Accessed 2 Apr 2017."},{"key":"2532_CR35","unstructured":"WHO. Global Vaccine Action Plan 2011-2020. Geneva: WHO Press; 2013. Available at: http:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/GVAP_doc_2011_2020\/en\/. Accessed 2 Apr 2017."},{"key":"2532_CR36","unstructured":"Ministry of Health and Family Welfare, PIB Press Release Mission Indradhanush impact. Available at: http:\/\/pib.nic.in\/newsite\/PrintRelease.aspx?relid=160063. Accessed 25 July 2017."},{"key":"2532_CR37","unstructured":"New Vaccines in India\u2019s Universal Immunization Program. Available at: http:\/\/www.thehindubusinessline.com\/economy\/policy\/four-vaccines-added-to-indias-immunisation-programme\/article6173880.ece and PCV introduction http:\/\/pib.nic.in\/newsite\/PrintRelease.aspx?relid=161763. Accessed 25 July 2017."},{"key":"2532_CR38","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1016\/j.vaccine.2012.05.045","volume":"30","author":"JE Graham","year":"2012","unstructured":"Graham JE, Borda-Rodriguez A, Huzair F, Zinck E. Capacity for a global vaccine safety system: the perspective of national regulatory authorities. Vaccine. 2012;30:4953\u20139.","journal-title":"Vaccine"},{"key":"2532_CR39","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1016\/j.vaccine.2015.04.038","volume":"33","author":"R Butler","year":"2015","unstructured":"Butler R, MacDonald NE; The SAGE working group on vaccine hesitancy. Diagnosing the determinants of vaccine hesitancy in specific subgroups; the guide to tailoring immunization programmes (TIP). Vaccine. 2015;33:4176\u20139.","journal-title":"Vaccine"},{"key":"2532_CR40","doi-asserted-by":"publisher","unstructured":"Peretti-Watel P, Larson HJ, Ward JK, Schulz WS, Verger P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLOS Curr Outbreaks. 2015. Edition 1. https:\/\/doi.org\/10.1371\/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289.","DOI":"10.1371\/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289"},{"key":"2532_CR41","first-page":"297","volume":"88","author":"Global Polio Eradication Initiative","year":"2013","unstructured":"Global Polio Eradication Initiative. 8th meeting of the independent monitoring board. Wkly Epidemiol Rec. 2013;88:297\u2013300.","journal-title":"Wkly Epidemiol Rec"},{"key":"2532_CR42","unstructured":"National Family Health Survey \u2013 4, India factsheet (2015\u201316). International I for Population Sciences. Available at: http:\/\/rchiips.org\/NFHS\/pdf\/NFHS4\/India.pdf. Accessed 2 Apr 2017."}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-017-2532-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2532-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2532-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T06:01:01Z","timestamp":1660888861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-017-2532-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2532"],"URL":"https:\/\/doi.org\/10.1007\/s12098-017-2532-9","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,23]]},"assertion":[{"value":"3 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of Funding"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}